Cargando…
Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin
Autores principales: | Batta, Kiran, Bossenbroek, Hasse M., Pemmaraju, Naveen, Wilks, Deepti P., Chasty, Richard, Dennis, Mike, Milne, Paul, Collin, Matthew, Beird, Hannah C., Taylor, Justin, Patnaik, Mrinal M., Cargo, Catherine A., Somervaille, Tim C. P., Wiseman, Daniel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550946/ https://www.ncbi.nlm.nih.gov/pubmed/33833384 http://dx.doi.org/10.1038/s41375-021-01228-y |
Ejemplares similares
-
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm
por: Beird, Hannah, et al.
Publicado: (2023) -
Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms
por: Patnaik, Mrinal M., et al.
Publicado: (2018) -
Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)
por: Beird, Hannah C., et al.
Publicado: (2019) -
Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm
por: Economides, Minas P., et al.
Publicado: (2019) -
P691: MULTIOMIC SINGLE-CELL APPROACH REVEALED CLONAL ARCHITECTURE OF KIT MUTATIONS IN CHRONIC MYELOMONOCYTIC LEUKAEMIA PATIENTS WITH/WITHOUT SYSTEMIC MASTOCYTOSIS
por: Wang, Yu-Hung, et al.
Publicado: (2023)